About Breast-Women's Cancer 2024

After a successful 2023 edition, Scholars Conferences welcome all to the "5th Edition Global Summit on Breast and Women's Cancer" held during 24-25 June 2024 at Rome, Italy. Main theme of the conference is "Frontiers in Breast and Women's Cancer Research and Therapy".

Breast-Women's Cancer 2024 is a congress designed for researchers who work in breast cancer & women's cancers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care.

Breast-Women's Cancer 2024 annual event brings together as many as 100+ global and regional experts in the field of breast and women's cancer including clinicians, policy makers, patient advocates and care partners from all around the globe to share the latest advances and techniques for both early and late stage interventions with a strong focus on improving capacity around breast cancer early detection, treatment, support and advocacy.

The program has been the catalyst for the building of an informal coalition for women’s cancers in the globe. Breast-Women's Cancer 2024 program agendas have included; advances in treatment, clinician capacity building, strengthening and expanding experience sharing among breast cancer support groups, the importance of collecting and publishing evidence-based data, regional coalition building, peer-to-peer support training, advanced breast cancer, advocacy and how it relates to civil society and policy makers, including best practices for working with governments to affect positive policy change. 

The focus of this Breast-Women's Cancer 2024 was to share the latest information and innovations surrounding breast cancer, improving capacity for breast cancer early detection and expanding and sharing experiences among cancer support groups in an effort to enhance patients’ understanding of the disease and improve their quality of life.

Breast-Women's Cancer 2024 edition focused on (Objectives):

With an overarching goal of optimizing the management of primary breast cancer women, the event's aims are:

• Recent developments in novel diagnostics, biomarkers and treatments in breast cancer and others
• The role of antibody drug conjugates in HER2 non overexpressing breast cancers and others
• New strategies for HER2 positive, luminal and triple negative breast cancers and others
• Special considerations for young patients with breast cancer and others

• To develop an in-depth understanding around the biology and treatment options
• To explore the specific physical and psychosocial needs and consideration including patients perspective
• To gain insight into the development of a holistic and multidisciplinary management approach and the importance of supporting research

Is this for you?

We welcome members of multidisciplinary clinical and research teams with an interest in this area, including breast surgeons, oncologists, geriatricians, pathologists, clinical nurse specialists, researchers, and their trainees, as well as patient advocates.

Past delegates also include pharmacists, medical physicists, patients and their careers.

Upcoming Conference: Cancer Science 2024 | September 23-25, 2024 | Singapore

Cancer Science 2023 Past Conference Report

Scholars Conferences extends its heartfelt gratitude to all the members of the Organizing Committee, Chairs, Co-chairs, Keynote Speaker, Speakers, Students, Media Partners, and everyone who contributed to the conference's resounding success. The 5th Edition World Congress on Cancer Research and Oncology was seamlessly executed as a Hybrid Event from October 23-25, 2023 at Tokyo, Japan and Online. The Cancer Science Conference 2023 garnered an overwhelming response from participants.

Serving as a global platform, Cancer Science Conference 2023 facilitated fruitful discussions on the latest breakthroughs in Cancer Science, Cancer Research and oncology. The esteemed speakers highlights the new innovative technology in Radiation Oncology, Surgical Oncology, Chemotherapy, Colorectal Cancer, Stem cell Therapy, breast cancer, Immunotherapy, Cancer Epidemiology, Ovarian Cancer, Gynecologic Cancer, Cancer Genetics, Cancer Research and oncology and assisted reproductive technology and all Cancer and Oncology related subjects.

The conference commenced with a captivating opening ceremony, followed by a series of lectures delivered by both Distinguished Guests and Keynote Forum members. A highlight of the event was the Keynote Forum, where leading scientists enriched the gathering with their insightful presentations, elevating the conference to remarkable heights.

Cancer Science Conference Previous Conferences Speaker, Keynote Speakers and Poster Presenters:

• Guan Chen, Medical college of Wisconsin, United States
  
• Kui Ming Chan, CITY UNIVERSITY OF HONG KONG
• Vimolmas Tansathitaya, Mahidol University, Thailand
• Blake McKinley, Mayo Clinic, United States
• Petra Borilova Linhartova, RECETOX, Masaryk University, Czech Republic
• Declan Sculthorpe, University of Nottingham King's Meadow Campus, Lenton Lane Nottingham, United Kingdom
• Franco Musio, Franco Musio M.D. Medical Consultation Group, United States
• Marisa Fazzino, National Cancer Control Program, Uruguay
• Sheron Tannara Vargas, UFCSPA, Brazil
• Ziad Alosaimi, Umm Al-Qura,Saudi Arabia
• Jing Huang, Southeast University, China
• Xiao-Mei Qi, Medical college of Wisconsin, United States
• Dörthe Schaffrin-Nabe, Praxis fur Hamatologie und Onkologie, Germany
• Hamdi Al Shenawi, Arabian Gulf University, Bahrain
• Brandon Lucke Wold, West Virginia University, United States
• Swapna Ravi, Gundersen Health System, United States
• Haim Kaplan, Haim Kaplan Ltd,Israel
• Ozge Cevik, Adnan Menderes University, School of Medicine, Aydin, Turkey
• Huan Gui, Guizhou university, China
• Marwan Obeid, King Hussein Cancer Centre, Jordan
• Rafiah Kanwal, University of Management and Technology, Pakistan
• Shinichi Hori, Institute for Image Guided Therapy, Japan
• Beatriz Pinto, Polytechnic Institute of Cávado and Ave (IPCA),Portugal
• Lei Huo, The University of Texas MD Anderson Cancer Center, United States
• Julie Getz, University of Arizona, United States
• Andreana Andrioiti, National and Kapodistrian University of Athens, Medical School, Greece
• Vincent Ouellette, University Laval, Canada
• Atziri Corin Chavez Alvarez, University Laval, Canada
• Tinatin Alaverdashvili, Todua Clinic, Georgia

Upcoming Conference: 5th Edition Scholars Global Summit on Breast and Women’s Cancer | June 24-25, 2024 |Rome, Italy